Literature DB >> 4964449

A study of pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: clinical characteristics. XX. A report of the Veterans Administration-armed forces cooperative study on the chemotherapy of tuberculosis.

J H Bates.   

Abstract

Entities:  

Mesh:

Year:  1967        PMID: 4964449     DOI: 10.1164/arrd.1967.96.6.1151

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  12 in total

Review 1.  Treatment of pulmonary disease caused by opportunist mycobacteria.

Authors:  J Banks
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

Review 2.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

3.  Mycobacteriosis due to other than M. tuberculosis.

Authors:  J E Hiltz; G A Kloss
Journal:  Can Med Assoc J       Date:  1968-11-16       Impact factor: 8.262

4.  Rapid radiometric method for determining drug susceptibility of Mycobacterium avium-intracellulare.

Authors:  B G Yangco; E A Eikman; D A Solomon; S C Deresinski; J A Madden
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

5.  First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.

Authors: 
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

6.  Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.

Authors:  Emily Henkle; Katrina Hedberg; Sean Schafer; Shannon Novosad; Kevin L Winthrop
Journal:  Ann Am Thorac Soc       Date:  2015-05

7.  Therapeutic efficacy of liposome-entrapped rifampin against Mycobacterium avium complex infection induced in mice.

Authors:  H Saito; H Tomioka
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

8.  Niacin, nitrate and pyrazinamide studies using Middlebrook 7H10 Broth.

Authors:  J J Damato; M T Collins; J K McClatchy
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

9.  Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response.

Authors:  J Banks; A M Hunter; I A Campbell; P A Jenkins; A P Smith
Journal:  Thorax       Date:  1983-04       Impact factor: 9.139

10.  Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.